PrivateEquity

Private Equity Co-Investments: Targeting Value Amid Higher Valuations November 8, 2021

November 2021 - Private Equity

by John Hancock Investment Management

To read the entire article click here.

When executed alongside proven sponsors in opportunities aligned with their areas of expertise, private equity co-investments remain an attractive source of expected investment returns and a highly efficient way for investors to gain targeted exposure to leveraged buyouts. We review the co-investment market opportunity set today, with an emphasis on value creation in software, tech-enabled business services, and healthcare, areas poised for growth no matter what path the economy takes from here. We also note the diversifying characteristics of certain financial services, such as insurance brokers and registered investment advisers (RIAs).

Send The Author A Message

Send Message

Access Over 250K+ Industry Headlines, Posts and Updates

You May Also Enjoy The Following Posts

Andrea Alms Video: Money In Motion 141 - JP Morgan Healthcare Conference 2025
1mo ago PrivateEquity BrookDell Partners

Not a member yet?

Join AlphaMaven

The Premier Alternative Investment
Research and Due Diligence Platform for Investors

Free Membership for Qualified Investors and Industry Participants

Easily Customize Content to Match Your Investment Preferences
Breaking News 24/7/365
Daily Newsletter & Indices
Alternative Investment Listings & LeaderBoards
Industry Research, Due Diligence, Videos, Webinars, Events, Press Releases, Market Commentary, Newsletters, Fact Sheets, Presentations, Investment Mandates, Video PitchBooks & More!
Company Directory
Contact Directory
Member Posts & Publications
Alpha University Video Series to Expand Investor Knowledge
AUM Accelerator Program (designed for investment managers)
Over 450K+ Industry Headlines, Posts and Updates

ALL ALPHAMAVEN CONTENT IS FOR INFORMATIONAL PURPOSES ONLY. CONTENT POSTED BY MEMBERS DOES NOT NECESSARILY REFLECT THE OPINION OR BELIEFS OF ALPHAMAVEN AND HAS NOT ALWAYS BEEN INDEPENDENTLY VERIFIED BY ALPHAMAVEN. PAST PERFORMANCE IS NOT INDICATIVE OF FUTURE RESULTS. THIS IS NOT A SOLICITATION FOR INVESTMENT. THE MATERIAL PROVIDED HEREIN IS FOR INFORMATIONAL PURPOSES ONLY. IT DOES NOT CONSTITUTE AN OFFER TO SELL OR A SOLICITATION OF AN OFFER TO BUY ANY INTERESTS OF ANY FUND OR ANY OTHER SECURITIES. ANY SUCH OFFERINGS CAN BE MADE ONLY IN ACCORDANCE WITH THE TERMS AND CONDITIONS SET FORTH IN THE INVESTMENT'S PRIVATE PLACEMENT MEMORANDUM. PRIOR TO INVESTING, INVESTORS ARE STRONGLY URGED TO REVIEW CAREFULLY THE PRIVATE PLACEMENT MEMORANDUM (INCLUDING THE RISK FACTORS DESCRIBED THEREIN), THE LIMITED PARTNERSHIP AGREEMENT AND THE SUBSCRIPTION DOCUMENTS, TO ASK SUCH QUESTIONS OF THE INVESTMENT MANAGER AS THEY DEEM APPROPRIATE, AND TO DISCUSS ANY PROSPECTIVE INVESTMENT IN THE FUND WITH THEIR LEGAL AND TAX ADVISERS IN ORDER TO MAKE AN INDEPENDENT DETERMINATION OF THE SUITABILITY AND CONSEQUENCES OF AN INVESTMENT.